The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global hydrocephalus shunts market was valued at US$ 412.6 Million in 2021.
We expect the global hydrocephalus shunts market to exhibit a CAGR of 4.20% during 2022-2027.
The sudden outbreak of the COVID-19 pandemic had led to postponement of elective hydrocephalus treatment procedures to reduce the risk of coronavirus infection upon hospital visits, thereby negatively impacting the global market for hydrocephalus shunts.
The rising prevalence of brain and neurological disorders, along with the increasing adoption of hydrocephalus shunts to treat hydrocephalus among infants that could lead to the enlargement of the head and brain damage, is primarily driving the global hydrocephalus shunts market.
Based on the type, the global hydrocephalus shunts market has been segmented into ventriculo-peritoneal, ventriculo-atrial, ventriculo-pleural, and lumbo-peritoneal. Among these, ventriculo-peritoneal currently holds the majority of the total market share.
Based on the product type, the global hydrocephalus shunts market can be divided into hydrocephalus valves and hydrocephalus catheters. Currently, hydrocephalus valves exhibit a clear dominance in the market.
Based on the age group, the global hydrocephalus shunts market has been categorized into infants, children, and adults. Among these, children currently account for the majority of the global market share.
Based on the end user, the global hydrocephalus shunts market can be segregated into hospitals and ambulatory surgical centers. Currently, hospitals hold the largest market share.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global hydrocephalus shunts market include Argi Group, B. Braun Melsungen AG, Christoph Miethke GmbH & Co. KG, G. Surgiwear Ltd., HLL Lifecare Limited, Integra LifeSciences, Kaneka Medix Corporation (Kaneka Corporation), Medtronic Plc, Natus Medical Incorporated, Sophysa, Spiegelberg GmbH & Co. KG (SHS Medizintechnik Holding GmbH), and TKB Corporation.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at